17 reports

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## Johnson & Johnson ## ## ## ## ## ## ## ## Astellas Pharma Inc ## ## ## ## ## ## ## ## Takeda Pharmaceutical Co Ltd ## ## ## ## ## ## ## ## Incyte Corp ## ## ## ## ## ## ## ## Bellicum Pharmaceuticals Inc ## ##

  • Leukemia
  • Monoclonal Antibody
  • Pharmaceutical
  • United States
  • World

THE VARIOUS TCR BASED IMMUNOTHERAPIES THAT ARE BEING DEVELOPED BY THE COMPANY ARE AS FOLLOWS: LTCR-H##-##: PREVENTION OF HEPATOCELLULAR CARCINOMA RECURRENCE POST- LIVER TRANSPLANTATION (PHASE I) LTCR-H##-##: TREATMENT OF HEPATOCELLULAR CARCINOMA RECURRENCE POST-

  • Leukemia
  • Company
  • Market Size
  • Juno Therapeutics Inc.
  • Novartis AG
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Blood Disease
  • Clinical Trial
  • Leukemia
  • Transplantation
  • Novartis AG
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

One patient with a very good partial response according to response criteria was taken off the study to receive stem cell transplantation.

  • Clinical Trial
  • Drug Development
  • Leukemia
  • World
  • Product Initiative

It is indicated for the prophylaxis of organ rejection in adult patients at low-moderate immunologic risk receiving a kidney transplant and liver transplant.

  • Leukemia
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • Merck & Co., Inc.
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

One patient with a very good partial response according to response criteria was taken off the study to receive stem cell transplantation.

  • Clinical Trial
  • Drug Development
  • Leukemia
  • World
  • Product Initiative

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Blood Disease
  • Clinical Trial
  • Leukemia
  • World
  • GlaxoSmithKline plc
  • 5. All the trials included are unique trials.

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## Takeda Pharmaceutical Company Ltd ## ## ## ## ## ## ## ## Pfizer Inc ## ## ## ## ## ## ## ## Neopharm Ltd ## ## ## ## ## ## ## ## Mallinckrodt Plc ## ## ## ## ## ## ## ## Bellicum Pharmaceutic

  • Drug Development
  • Leukemia
  • Pharmaceutical
  • Transplantation
  • World
  • 5. All the trials included are unique trials.

## ## ## ## ## ## ## ## Italy ## ## ## ## ## ## ## ## Germany ## ## ## ## ## ## ## ## United Kingdom ## ## ## ## ## ## ## ## France ## ## ## ## ## ## ## ## Canada ## ## ## ## ## ## ## ## Source: GlobalData' s Pharma Intellige

  • Blood Disease
  • Leukemia
  • Therapy
  • Transplantation
  • Novartis AG

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Blood Disease
  • Chemotherapy
  • Clinical Trial
  • Leukemia
  • GlaxoSmithKline plc

Median number of metastatic sites was ## (range ##-##) including brain, liver, and lung.

  • Leukemia
  • Therapy
  • United States
  • Product Initiative
  • Novartis AG
  • Clinical Trial profile. 135 Trial Title

The prominent features of this report are - ##.

  • Leukemia
  • Pharmaceutical
  • Therapy
  • World
  • Product Initiative
  • Clinical Trial Profile Snapshots

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Leukemia
  • Monoclonal Antibody
  • Pharmaceutical
  • World
  • Product Initiative
  • Clinical Trial Profile Snapshots

The prominent features of this report are - ##.

  • Leukemia
  • Monoclonal Antibody
  • Therapy
  • World
  • Product Initiative

It is indicated for the prophylaxis of organ rejection in adult patients at low-moderate immunologic risk receiving a kidney transplant and Liver transplant.

  • Leukemia
  • Lung Cancer
  • United States
  • Product Initiative
  • ARIAD Pharmaceuticals, Inc.

The drug candidate targets liver glucokinase.

  • Leukemia
  • Monoclonal Antibody
  • Targeted Therapy
  • Therapy
  • Pfizer Inc.
  • Novartis AG - Dormant Developmental Projects,2016
  • SOTRASTAURIN ACETATE

It is indicated for the prophylaxis of organ rejection in adult patients at low-moderate immunologic risk receiving a kidney transplant and Liver transplant.

  • Cancer
  • Leukemia
  • Targeted Therapy
  • Therapy
  • Novartis AG